| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer
|
De Meerleer, Gert
|
|
|
5 |
4 |
p. 428-429
|
article
|
| 2 |
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
|
Salazar, Aina
|
|
|
5 |
4 |
p. 460-463
|
article
|
| 3 |
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate Cancer
|
Walz, Jochen
|
|
|
5 |
4 |
p. 401-402
|
article
|
| 4 |
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations
|
Hensley, Patrick J.
|
|
|
5 |
4 |
p. 403-411
|
article
|
| 5 |
Contents
|
|
|
|
5 |
4 |
p. iii-v
|
article
|
| 6 |
Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis” [Eur Urol Oncol 2021;4:927–42]
|
Laukhtina, Ekaterina
|
|
|
5 |
4 |
p. 480-481
|
article
|
| 7 |
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma
|
Lenfant, Louis
|
|
|
5 |
4 |
p. 464-471
|
article
|
| 8 |
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer
|
Cani, Andi K.
|
|
|
5 |
4 |
p. 430-439
|
article
|
| 9 |
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
|
Kawada, Tatsushi
|
|
|
5 |
4 |
p. 390-400
|
article
|
| 10 |
Editorial Board
|
|
|
|
5 |
4 |
p. i-ii
|
article
|
| 11 |
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
|
Stenzl, Arnulf
|
|
|
5 |
4 |
p. 449-450
|
article
|
| 12 |
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial
|
Gallioli, Andrea
|
|
|
5 |
4 |
p. 440-448
|
article
|
| 13 |
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
|
Weiner, Adam B.
|
|
|
5 |
4 |
p. 377-387
|
article
|
| 14 |
Managing Prostate Cancer Recurrence After Local Treatment: Balancing Benefits Against Risks in a Rapidly Changing Environment
|
Tombal, Bertrand
|
|
|
5 |
4 |
p. 388-389
|
article
|
| 15 |
Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups
|
Hurst, Rachel
|
|
|
5 |
4 |
p. 412-419
|
article
|
| 16 |
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
|
Martini, Alberto
|
|
|
5 |
4 |
p. 451-459
|
article
|
| 17 |
Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Kalampokis, Nikolaos
|
|
|
5 |
4 |
p. 472-473
|
article
|
| 18 |
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002
|
Guler, Ozan Cem
|
|
|
5 |
4 |
p. 475-476
|
article
|
| 19 |
Reply to Nikolaos Kalampokis, Nikolaos Grivas, Markos Karavitakis, and Henk van der Poel’s Letter to the Editor re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Morote, Juan
|
|
|
5 |
4 |
p. 474
|
article
|
| 20 |
Reply to Ozan Cem Guler and Cem Onal’s Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005
|
Pan, Jian
|
|
|
5 |
4 |
p. 479
|
article
|
| 21 |
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
|
Guler, Ozan Cem
|
|
|
5 |
4 |
p. 477-478
|
article
|
| 22 |
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study
|
Pan, Jian
|
|
|
5 |
4 |
p. 420-427
|
article
|
Journal description